Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,190.00
Bid: 12,210.00
Ask: 12,214.00
Change: 162.00 (1.35%)
Spread: 4.00 (0.033%)
Open: 12,036.00
High: 12,214.00
Low: 12,024.00
Prev. Close: 12,028.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MORNING BID-Asking for more stimulus?

Wed, 08th Jul 2020 09:04

* A look at the day ahead from EMEA deputy markets editor
Sujata
Rao. The views expressed are her own

LONDON, July 8 (Reuters) - Share markets are wavering after
snapping a five-day winning streak on Tuesday when world stocks
tumbled 1% and all three U.S. indexes closed in the red.

This morning, Wall Street futures and European equities are
both lower, Treasury yields are close to the one-week lows they
plumbed on Tuesday and German yields are 2 basis points lower.
China's Shanghai and Shenzhen benchmarks continued to march
higher in what's widely seen as a state-sanctioned rally.

In keeping with the jittery mood, the dollar is holding firm
as is gold. The Chinese rally has stoked demand for commodities,
pushing Shanghai copper to its highest in more than a year.
Chinese equity gains – the seventh day in a row – also pushed
emerging equities 0.7% higher.

The most obvious explanation for the pullback is the rise in
U.S. coronavirus cases, with 3 million confirmed cases and
localised activity restrictions. Atlanta Fed President Rafael
Bostic said there was a real sense the coronavirus crisis "might
go on longer than we have planned for".

Criticism of U.S President Donald Trump's handling of the
crisis is seen damaging his re-election chances, forcing Wall
Street to contend with the possibility of a Democrat
administration, higher taxes and tighter regulation.

Markets may also be hankering after another dose of stimulus
– Fed Vice Chair Richard Clarida said there was no limit to how
much bond buying the Fed could do.

The Cleveland Fed's Loretta Mester, meanwhile, called for
more help from the fiscal side. She may have hit the nail on the
head -- there's some unease as the scheme to supplement U.S.
jobless payments expires at the end of July just as the COVID-19
spike threatens to derail new hiring.

Consultancy Oxford Economics points out the worsening
coronavirus comes just as liquidity provision from central banks
and governments is slowing – central banks' balance-sheet growth
isn't accelerating any more, while some governments seem wary of
further fiscal measures that risk adding to debt.

Barclays said this morning in its annual equity-gilt study
that while all the extra borrowing is needed, deficits will need
to be addressed some day, with higher taxes part of the
solution.

Speaking of fiscal stimulus, British finance minister Rishi
Sunak is expected to announce measures to counter the jump in
unemployment. Aside from spending 3 billion pounds to improve
energy efficiency, he could announce VAT cuts, lower property
purchases taxes and vouchers to aid hospitality businesses. The
pound is holding near three-week highs before his speech.

In European corporate news, AstraZeneca and Merck &
Co said their cancer treatment Lynparza won European
Union approval for treating a form of pancreatic cancer.

Shares in Traton were down 3.6% after the company
announced management changes. Deutsche Post
was up 1.3% after reporting a 16% rise in
second-quarter operating profit.

In coronavirus-linked bad news, logistics company DHL may
cut as many as 2000 UK jobs, the Unite trade union said;
FirstGroup warned on its ability to continue as a going
concern, after posting an annual operating loss and plunging
passenger volumes; OMV second-quarter output dropped
5% in wake of coronavirus pandemic.

In emerging markets, China's yuan is near 7 to the dollar
after briefly breaking through the threshold on Tuesday.
Nigeria' naira fell 5.5% on Tuesday following central bank FX
sales at a lower rate -- possibly after pressure from lenders
and markets to unify its plethora of exchange rates.

Non-deliverable forwards see the naira losing a fifth of its
value over the next 12 months.
(Editing by Larry King
)

More News
23 Oct 2023 08:45

TOP NEWS: AstraZeneca says Enhertu approved by European Commission

(Alliance News) - AstraZeneca PLC on Monday said its Enhertu treatment has been approved by the European Commission to treat adult lung cancer patients.

Read more
23 Oct 2023 07:46

LONDON BRIEFING: Keller expects higher profit; Upland rejects approach

(Alliance News) - Stocks in London are set to open slightly higher on Monday, as risk sentiment improves after a difficult period for markets last week.

Read more
18 Oct 2023 09:04

AstraZeneca drug Solaris approved in China as NMOSD treatment

(Alliance News) - AstraZeneca PLC on Wednesday announced that eculizumab, whose brand name is Solaris, has been approved in China to treat patients with neuromyelitis optica spectrum disorder

Read more
17 Oct 2023 12:06

LONDON MARKET MIDDAY: European markets uneasy but FTSE 100 outperforms

(Alliance News) - London's FTSE 100 higher was higher around midday, though it was defensive stocks such as utilities and pharmaceuticals which led the charge, suggesting there is still lingering discomfort in markets amid tensions in the Middle East.

Read more
16 Oct 2023 08:34

TOP NEWS: AstraZeneca's cancer drug gets priority review from US FDA

(Alliance News) - AstraZeneca PLC on Monday said that its new drug application for Tagrisso has been granted priority review in the US, after trial results extended progression-free survival.

Read more
4 Oct 2023 12:14

IN BRIEF: AstraZeneca's Forxiga drug shows positive results in trial

AstraZeneca PLC - Cambridge-based pharmaceutical maker - Says Forxiga drug meets primary endpoints in T2NOW phase three trial and shows "clinically meaningful" improvements in the glycaemic control among type two diabetes patients between the ages of 10 and 17. Adds safety results in patient cohort were consistent with those in adults with type two diabetes.

Read more
3 Oct 2023 16:55

LONDON MARKET CLOSE: Stocks red as rate rise fears continue to grow

(Alliance News) - Stocks in London were lower at the close on Tuesday after unexpectedly strong US job openings data added to fears that interest rates in the world's largest economy will stay higher for longer.

Read more
3 Oct 2023 11:59

LONDON MARKET MIDDAY: HSBC and StanChart help FTSE 100 outperform

(Alliance News) - London's FTSE 100 grew in confidence as Tuesday morning progressed, going into the afternoon in the green and outperforming European peers.

Read more
3 Oct 2023 08:36

TOP NEWS: AstraZeneca settles Nexium and Prilosec litigation

(Alliance News) - AstraZeneca PLC on Tuesday said it has settled legal matters involving its Nexium acid reflux and Prilosec heartburn products, parting with USD425 million.

Read more
3 Oct 2023 07:41

LONDON BRIEFING: Greggs sales rise; boohoo cuts revenue outlook

(Alliance News) - London's FTSE 100 is set to fall further on Tuesday, after a sell-off at the start of the week, with hawkish words from a US central banker reinforcing the 'higher-for-longer' interest rates messaging.

Read more
3 Oct 2023 07:24

AstraZeneca agrees to settle most Nexium, Prilosec claims

(Sharecast News) - Global pharmaceutical company AstraZeneca has agreed to settle litigation on product liability related to two of its widely-used heartburn drugs, Nexium and Prilosec, it announced on Tuesday.

Read more
25 Sep 2023 09:13

LONDON BROKER RATINGS: Jefferies raises AstraZeneca to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
25 Sep 2023 07:43

LONDON BRIEFING: Stocks seen lower; Aviva buys AIG's UK protection arm

(Alliance News) - Stocks in London were set to open lower on Monday as investors eyed fresh concerns for the already fragile Chinese property sector.

Read more
22 Sep 2023 08:42

LONDON MARKET OPEN: Stocks slip after central bank rate calls

(Alliance News) - Stock prices in London opened lower on Friday, but managed to avoid the steep declines seen in New York, as investors mulled over an eventful week dominated by central bank decisions.

Read more
22 Sep 2023 08:13

TOP NEWS: AstraZeneca's datopotamab deruxtecan shows positive results

(Alliance News) - AstraZeneca PLC on Friday said phase three data showed that datopotamab deruxtecan delivered improvement in progression-free survival in breast cancer patients.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.